| pubmed-article:14984358 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:14984358 | lifeskim:mentions | umls-concept:C0029456 | lld:lifeskim |
| pubmed-article:14984358 | pubmed:issue | 5 Suppl | lld:pubmed |
| pubmed-article:14984358 | pubmed:dateCreated | 2004-2-26 | lld:pubmed |
| pubmed-article:14984358 | pubmed:abstractText | Osteoporosis is: (1) Underrated. Currently costs about 7 billion dollars annually in Australia. Has high morbidity and 2-3-fold increase in risk of death after any major osteoporotic fracture. Genetic factors contribute highly to risk, modified by lifestyle and hormonal factors. (2) Underdiagnosed. Bone density is a good predictor of subsequent risk. Anyone with a low-trauma fracture has osteoporosis unless proven otherwise. Every individual with a low trauma fracture should be investigated for exclusion of underlying osteoporosis and considered for effective treatment to reduce future fracture risk. More than 75% of women and about 90% of men with a high likelihood of osteoporosis are not investigated. (3) Undertreated. More than 75% of those affected are not treated. Effective treatments (eg, hormone replacement therapy, selective oestrogen receptor modifiers and bisphosphonates) reduce fracture risk by 30%-60%. Simple measures like vitamin D and calcium supplementation and use of hip protectors can reduce hip fractures, particularly in institutionalised and housebound elderly people | lld:pubmed |
| pubmed-article:14984358 | pubmed:language | eng | lld:pubmed |
| pubmed-article:14984358 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14984358 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:14984358 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14984358 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14984358 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14984358 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14984358 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14984358 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:14984358 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:14984358 | pubmed:issn | 0025-729X | lld:pubmed |
| pubmed-article:14984358 | pubmed:author | pubmed-author:NguyenTuan... | lld:pubmed |
| pubmed-article:14984358 | pubmed:author | pubmed-author:EismanJohn... | lld:pubmed |
| pubmed-article:14984358 | pubmed:author | pubmed-author:CenterJacquel... | lld:pubmed |
| pubmed-article:14984358 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:14984358 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:14984358 | pubmed:volume | 180 | lld:pubmed |
| pubmed-article:14984358 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:14984358 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:14984358 | pubmed:pagination | S18-22 | lld:pubmed |
| pubmed-article:14984358 | pubmed:dateRevised | 2005-11-16 | lld:pubmed |
| pubmed-article:14984358 | pubmed:meshHeading | pubmed-meshheading:14984358... | lld:pubmed |
| pubmed-article:14984358 | pubmed:meshHeading | pubmed-meshheading:14984358... | lld:pubmed |
| pubmed-article:14984358 | pubmed:meshHeading | pubmed-meshheading:14984358... | lld:pubmed |
| pubmed-article:14984358 | pubmed:meshHeading | pubmed-meshheading:14984358... | lld:pubmed |
| pubmed-article:14984358 | pubmed:meshHeading | pubmed-meshheading:14984358... | lld:pubmed |
| pubmed-article:14984358 | pubmed:meshHeading | pubmed-meshheading:14984358... | lld:pubmed |
| pubmed-article:14984358 | pubmed:meshHeading | pubmed-meshheading:14984358... | lld:pubmed |
| pubmed-article:14984358 | pubmed:meshHeading | pubmed-meshheading:14984358... | lld:pubmed |
| pubmed-article:14984358 | pubmed:meshHeading | pubmed-meshheading:14984358... | lld:pubmed |
| pubmed-article:14984358 | pubmed:meshHeading | pubmed-meshheading:14984358... | lld:pubmed |
| pubmed-article:14984358 | pubmed:meshHeading | pubmed-meshheading:14984358... | lld:pubmed |
| pubmed-article:14984358 | pubmed:meshHeading | pubmed-meshheading:14984358... | lld:pubmed |
| pubmed-article:14984358 | pubmed:meshHeading | pubmed-meshheading:14984358... | lld:pubmed |
| pubmed-article:14984358 | pubmed:meshHeading | pubmed-meshheading:14984358... | lld:pubmed |
| pubmed-article:14984358 | pubmed:meshHeading | pubmed-meshheading:14984358... | lld:pubmed |
| pubmed-article:14984358 | pubmed:meshHeading | pubmed-meshheading:14984358... | lld:pubmed |
| pubmed-article:14984358 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:14984358 | pubmed:articleTitle | Osteoporosis: underrated, underdiagnosed and undertreated. | lld:pubmed |
| pubmed-article:14984358 | pubmed:affiliation | Bone and Mineral Research Program, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia. | lld:pubmed |
| pubmed-article:14984358 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:14984358 | pubmed:publicationType | Review | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14984358 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14984358 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14984358 | lld:pubmed |
